fbpx Skip to main content

WEDNESDAY, Dec. 30, 2020 (HealthDay News) — Many bariatric surgery patients do not receive recommended postoperative nutritional and weight monitoring within general practice, according to a study published online Dec. 9 in the British Journal of General Practice.

Helen Parretti, M.B.B.S., Ph.D., from the University of East Anglia in the United Kingdom, and colleagues conducted a retrospective cohort study to examine whether nutritional and weight monitoring in primary care meets current clinical guidance for adults who had undergone bariatric surgery with a minimum of three years of follow-up after surgery, while focusing on those who were discharged from specialist care two years after surgery. Data were included for 3,137 participants with a median postsurgical follow-up of 5.7 years.

The researchers found that 45 to 59 percent of participants had an annual weight measurement. The proportion of patients with a record of annual nutritional blood tests was greatest for tests routinely conducted in primary care; for example, recorded hemoglobin measurement varied from 44.9 to 61.2 percent. In contrast, the investigators observed a low annual proportion of blood tests specific to bariatric surgery; for example, recorded copper measurement varied from 1.2 to 1.5 percent. Anemia was the most common deficiency. A low annual proportion of patients had prescriptions for recommended nutritional supplements.

“Patients are supported to make changes to their eating before surgery and these changes need to continue after surgery to help avoid putting weight back on and to keep well. In addition, it is important that patients take lifelong nutritional supplements after their surgery,” a coauthor said in a statement. “But patients need support to achieve this after their operations and current guidance recommends this is offered by general practitioners.”

Abstract/Full Text (subscription or payment may be required)

You May Also Like::  Telemedicine Use Increased Considerably During COVID-19

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More